Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22035,170,0.96 [0.73-1.28],0.8008481208521118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23036,182,1.18 [0.91-1.53],0.2063453660156489
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22787,1367,1.18 [1.07-1.30],0.0006807512005133
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Candidiasis,23046,364,1.17 [0.97-1.40],0.1002968937812297
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22368,3368,1.14 [1.07-1.21],4.017236943301602e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22344,3408,1.11 [1.04-1.18],0.0014548193883222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22843,1016,1.16 [1.04-1.29],0.0089446241028324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22974,78,0.79 [0.51-1.22],0.2948379978348661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20873,1082,1.13 [1.01-1.26],0.0266472634566415
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20157,1208,1.22 [1.10-1.35],0.0001525005275595
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19873,242,1.18 [0.94-1.48],0.1581044296340898
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16227,2212,1.11 [1.03-1.20],0.0063631439491409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19804,390,1.44 [1.21-1.70],2.6052603286561373e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23037,1210,1.19 [1.07-1.31],0.0008855936992454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,23131,449,1.13 [0.96-1.34],0.1512029806281352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22289,869,1.20 [1.06-1.35],0.0028395581383925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23058,1193,1.09 [0.99-1.21],0.0914643406792955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22010,183,1.18 [0.91-1.54],0.2136768129760959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23170,52,1.87 [1.27-2.76],0.0014777239688473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22908,1043,1.11 [1.00-1.24],0.059767473520978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22962,66,1.52 [1.02-2.26],0.0386217294320031
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23111,114,1.77 [1.33-2.35],8.215962090496363e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23093,96,1.94 [1.44-2.61],1.208487942348449e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21894,474,1.32 [1.13-1.54],0.0004426589460761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21694,274,1.11 [0.90-1.38],0.3350620876938504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21911,84,1.60 [1.13-2.28],0.0087248934355622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23151,66,0.82 [0.51-1.30],0.3931066989550231
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23116,139,1.19 [0.89-1.60],0.2401812694940766
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral warts,23028,51,1.19 [0.73-1.94],0.4782906276350491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23025,48,1.23 [0.75-2.01],0.4125917043478887
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,22864,334,0.87 [0.71-1.06],0.1679585212199702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23100,44,0.82 [0.46-1.44],0.4833074686496731
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23067,52,1.06 [0.64-1.73],0.8245664284885811
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,0.87 [0.63-1.21],0.4175547048744334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22805,1595,1.02 [0.93-1.12],0.6693817693980253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,23171,33,1.33 [0.74-2.37],0.341730147947262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23109,63,1.09 [0.69-1.71],0.7230974327322062
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23154,70,1.23 [0.82-1.85],0.3234584073404951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23145,427,0.94 [0.79-1.13],0.5278246570897036
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Caecum,23141,339,1.03 [0.85-1.25],0.7617300510741168
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23043,79,0.83 [0.54-1.28],0.4064528687020368
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,23137,267,1.06 [0.85-1.32],0.5861174443497474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,23100,403,0.96 [0.80-1.15],0.626117203246862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23050,706,1.01 [0.88-1.16],0.8600836252041834
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23127,542,1.02 [0.87-1.20],0.7845303215645354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18014,68,3.78 [2.89-4.94],1.625303661990104e-22
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18013,67,1.19 [0.77-1.83],0.4453636743468095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23140,95,0.93 [0.64-1.36],0.7242044054879442
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",23140,92,0.94 [0.64-1.38],0.7397744289667088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lung cancer and mesothelioma,15439,337,1.16 [0.94-1.42],0.1660070528449678
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,18008,62,4.29 [3.30-5.58],1.5431090346401158e-27
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18138,192,1.24 [0.96-1.60],0.0997899916629386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18230,284,1.01 [0.81-1.26],0.9347435980640928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18032,86,1.10 [0.74-1.64],0.6454313611501401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18082,136,0.93 [0.67-1.29],0.6692159086939408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18081,135,1.09 [0.79-1.50],0.5836837719964321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18024,78,0.97 [0.63-1.49],0.8982911131290877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,1.08 [0.98-1.19],0.1416818107363493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18086,140,0.78 [0.56-1.08],0.1346488585076599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18046,100,1.43 [1.01-2.02],0.0438200451597255
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18072,126,1.18 [0.86-1.63],0.3135953406040942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,23046,166,0.96 [0.72-1.28],0.7834062408259913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,23139,91,1.14 [0.80-1.65],0.4673411210474729
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanoma in situ,17977,71,1.06 [0.68-1.65],0.7881824282480547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18043,97,1.19 [0.83-1.71],0.3382201103401073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18107,161,1.50 [1.15-1.95],0.0026685370422002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18160,214,0.99 [0.76-1.29],0.9275630357140916
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18045,99,1.27 [0.89-1.80],0.1923120068135166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,23038,130,1.10 [0.80-1.50],0.5575088925013858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19114,1168,1.04 [0.93-1.16],0.4897569631533438
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19188,1242,1.06 [0.96-1.18],0.2686194644544354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22913,299,1.39 [1.15-1.68],0.0007966099997492
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21478,113,1.30 [0.94-1.80],0.1148474786710072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22680,66,1.57 [1.06-2.33],0.0247395113877836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22628,2704,1.09 [1.02-1.17],0.0133231955377197
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21927,60,1.55 [1.04-2.31],0.0297017538116544
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22753,52,0.68 [0.39-1.17],0.1644806580422835
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22800,1435,1.08 [0.98-1.19],0.1000605159885694
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22799,1434,1.08 [0.98-1.19],0.1068082961038725
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21465,100,1.06 [0.74-1.53],0.7350242242402518
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22937,1070,1.17 [1.05-1.30],0.0042817766274355
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22804,103,1.25 [0.89-1.75],0.1995887414283259
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22686,72,1.14 [0.75-1.74],0.5293833704237194
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22673,59,1.81 [1.23-2.66],0.0025303949229578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23011,310,0.91 [0.73-1.12],0.3628192923618732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23079,47,0.81 [0.47-1.41],0.4630743631015193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22954,253,0.87 [0.69-1.10],0.2534638392976167
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21941,74,0.65 [0.41-1.03],0.0683766741086938
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17090,368,1.29 [1.08-1.55],0.005699970249649
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21186,158,1.03 [0.77-1.37],0.8641189936564752
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21208,180,1.10 [0.84-1.43],0.4944999738980138
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16777,55,1.38 [0.87-2.19],0.1753862278516822
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21840,64,0.96 [0.61-1.52],0.8641737388052386
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21088,216,0.96 [0.75-1.23],0.737042953701627
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22676,605,1.09 [0.94-1.26],0.2571546139496822
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22308,237,1.05 [0.83-1.33],0.6955153634463378
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22239,168,1.06 [0.80-1.39],0.7052105897266545
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22876,1100,1.19 [1.07-1.32],0.0012859948455229
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19810,1056,1.15 [1.04-1.28],0.0088731137380275
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16794,72,0.73 [0.46-1.16],0.1794172784104035
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22311,37,0.85 [0.46-1.58],0.6023687917965306
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,16987,265,1.27 [1.03-1.58],0.0289106653896735
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16791,69,1.52 [1.03-2.24],0.0356786294591996
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20489,3767,1.10 [1.04-1.17],0.0012614453306607
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,16899,177,1.06 [0.81-1.40],0.6639249947421413
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17270,548,1.18 [1.02-1.38],0.0296459411196534
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23113,267,1.14 [0.92-1.42],0.2188283186347638
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22930,84,1.01 [0.68-1.50],0.9682469054176698
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16870,148,1.28 [0.96-1.70],0.0924373088778088
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16784,62,1.22 [0.78-1.91],0.373542261414836
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22995,721,1.03 [0.90-1.18],0.6487514970644768
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17022,300,1.28 [1.04-1.58],0.0177749971462954
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17089,367,1.10 [0.91-1.33],0.3474775999817612
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17428,706,1.15 [1.00-1.31],0.0445901180874993
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16864,142,0.99 [0.72-1.35],0.9447986605832934
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22924,78,1.02 [0.68-1.54],0.9107455024045328
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17279,557,1.26 [1.08-1.45],0.002498105992447
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17103,381,1.09 [0.90-1.31],0.3751209030736643
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20940,68,1.20 [0.79-1.82],0.403751751454135
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21762,5040,1.09 [1.04-1.15],0.0009070227416996
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22294,20,0.80 [0.34-1.88],0.6059953058662448
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22295,21,0.91 [0.40-2.07],0.8218297427747191
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23001,1722,0.92 [0.84-1.01],0.0649472139889278
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22998,1718,0.92 [0.84-1.00],0.0640476586998488
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22295,21,1.40 [0.70-2.81],0.3412463998916991
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22908,779,1.07 [0.94-1.22],0.3001780655701708
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18299,1577,1.16 [1.06-1.27],0.0011908753378043
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23159,262,1.12 [0.90-1.39],0.3189966070674673
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22178,107,1.28 [0.92-1.78],0.1500984840711357
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22202,73,1.10 [0.73-1.67],0.6423627740940403
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22210,81,1.45 [1.02-2.08],0.040668862634775
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16787,65,0.99 [0.63-1.57],0.9719839357791504
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20467,160,1.17 [0.88-1.54],0.2830724204538143
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2421,119,1.24 [0.89-1.71],0.1976359392839447
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2579,308,0.89 [0.72-1.10],0.2694298404193063
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20402,95,1.32 [0.94-1.83],0.1052393735102097
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2379,79,1.43 [0.97-2.10],0.0676593918476269
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22405,2098,1.11 [1.03-1.20],0.0073676605757724
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22427,356,0.89 [0.73-1.09],0.2560939045882318
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21108,236,1.25 [1.00-1.56],0.0469457158129949
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17499,777,1.19 [1.05-1.35],0.0058011071529752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23048,246,0.97 [0.77-1.22],0.7803410265843376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21983,270,0.83 [0.65-1.04],0.1058883591656237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,20318,1461,1.00 [0.91-1.10],0.9978578888796517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22088,375,0.95 [0.79-1.15],0.6268891661814582
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21796,83,1.50 [1.06-2.13],0.0232112972386374
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21955,242,1.33 [1.07-1.65],0.0096059187346623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13569,2245,0.94 [0.87-1.02],0.1238560429734511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,AV-block,18637,599,1.06 [0.91-1.23],0.4549623817868143
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23097,523,0.96 [0.82-1.13],0.6335069696778306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,11575,251,1.12 [0.89-1.41],0.3224104599268845
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18235,197,0.96 [0.74-1.25],0.7522815434911969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18146,108,0.79 [0.54-1.14],0.2080535293504772
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23172,66,1.11 [0.71-1.74],0.6524925511332931
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,19352,1314,1.01 [0.91-1.11],0.9068331868746076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21399,2565,1.10 [1.02-1.18],0.0105705968227042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19502,7526,1.03 [0.99-1.08],0.1105278603475541
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21984,270,0.96 [0.76-1.19],0.6890335960610292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Endocarditis,18119,81,0.97 [0.64-1.46],0.8843660565929055
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22867,1290,1.03 [0.93-1.14],0.5309653648275585
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,20666,6561,1.06 [1.01-1.11],0.0143381354059361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20688,6583,1.06 [1.01-1.11],0.0141294693943946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22952,103,0.89 [0.62-1.30],0.5524306647914128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14282,177,1.22 [0.94-1.58],0.1365555933359662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14270,165,1.30 [1.00-1.68],0.0478629373372212
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,23025,1202,1.22 [1.11-1.35],7.96680161201893e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22127,116,0.76 [0.53-1.08],0.1291703899252909
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21536,2679,1.06 [0.99-1.14],0.0775140111405198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22749,632,1.14 [0.99-1.32],0.0616105079708449
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18443,405,1.13 [0.95-1.36],0.1677922731174508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22460,1037,1.07 [0.96-1.20],0.2078258493644813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19756,899,1.13 [1.01-1.27],0.0409474336552132
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23015,212,1.20 [0.95-1.53],0.1294359519899229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23119,367,1.00 [0.82-1.20],0.9649098727983776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Oesophageal varices,21779,65,0.91 [0.57-1.44],0.6797454051951826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other aneurysm,21808,95,1.15 [0.80-1.65],0.4389542661480383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,18505,467,1.20 [1.02-1.41],0.0255264150883426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21847,134,1.48 [1.12-1.95],0.0057724821431033
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21982,269,0.99 [0.79-1.24],0.913641933262165
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18228,190,0.94 [0.71-1.23],0.6343845903622491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other disorders of veins,21811,97,1.05 [0.73-1.52],0.7802411841450068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21762,48,0.96 [0.56-1.64],0.8772218542356974
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21621,84,0.98 [0.66-1.47],0.93080003010311
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21818,104,0.99 [0.69-1.43],0.9686063266530984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19250,1212,1.00 [0.90-1.11],0.9939114340801776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21886,63,1.06 [0.67-1.68],0.8109756755475366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22274,561,1.19 [1.03-1.38],0.0209905535158307
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22538,351,1.33 [1.11-1.59],0.0022535037482451
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22184,647,1.09 [0.94-1.25],0.250942035923366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11695,371,0.84 [0.69-1.02],0.0801469678360417
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22183,515,1.19 [1.02-1.39],0.0237462173957655
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22064,350,0.91 [0.75-1.11],0.3606362879034887
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22676,489,1.03 [0.87-1.21],0.7300665206086523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23108,690,1.01 [0.88-1.17],0.843380238790643
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18495,457,0.95 [0.80-1.13],0.5521604813068594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22536,349,1.32 [1.10-1.58],0.0032892427165625
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21755,218,1.08 [0.84-1.38],0.5430360317079477
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22733,722,1.10 [0.96-1.25],0.1761076945455234
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22718,750,1.08 [0.95-1.24],0.2280103690708751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22108,46,0.71 [0.40-1.26],0.2385269750257403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21823,111,0.93 [0.66-1.32],0.6850208210818169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22360,243,1.07 [0.85-1.35],0.5575696205903438
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21728,305,1.06 [0.86-1.30],0.6102567801158406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,22081,367,0.95 [0.79-1.15],0.6130459002644715
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21731,73,0.90 [0.58-1.39],0.6325078474302948
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22936,767,0.95 [0.83-1.08],0.4323864249392739
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22978,482,1.15 [0.98-1.35],0.0896856460824138
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19913,943,1.14 [1.02-1.28],0.0256581401692066
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,22506,3536,1.07 [1.01-1.14],0.028222934848107
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22918,569,1.11 [0.95-1.28],0.1786574008443117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20105,1135,1.16 [1.04-1.28],0.0058206973947935
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19054,84,1.35 [0.95-1.94],0.0979853241705884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,22541,1490,1.08 [0.98-1.18],0.1082047657210858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20784,1814,1.07 [0.98-1.16],0.1293173650042799
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Vascular dementia,22668,150,0.87 [0.64-1.18],0.3712055808318786
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Alzheimer disease,23170,291,1.11 [0.90-1.37],0.3239556276310547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15404,57,1.11 [0.69-1.80],0.6678456649370057
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Bell's palsy,21849,71,0.84 [0.54-1.32],0.4518736316582684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22104,326,1.13 [0.93-1.38],0.2236189686468333
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral cysts,22781,231,1.04 [0.82-1.32],0.757279361290242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23087,354,1.02 [0.84-1.24],0.817377152128163
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22672,57,1.07 [0.67-1.73],0.7743856612786142
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23153,74,0.76 [0.49-1.19],0.2348382367664978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22639,89,1.07 [0.73-1.56],0.7348637881938402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,21601,274,0.95 [0.76-1.19],0.6722014159691225
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22645,1318,1.06 [0.96-1.17],0.2300041798740981
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23134,675,0.98 [0.85-1.13],0.7680245233260385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22642,2163,1.02 [0.94-1.10],0.5965116740040102
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Generalized epilepsy,22800,58,1.64 [1.10-2.45],0.0163506573714263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,23004,271,0.98 [0.78-1.23],0.8607551866391268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hydrocephalus,22605,55,1.31 [0.83-2.06],0.2500538387148222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23152,54,1.51 [0.98-2.34],0.0632043657243416
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21799,21,0.50 [0.21-1.20],0.1208786643057675
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21866,88,1.47 [1.04-2.08],0.0296809683201704
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Memory loss,22510,118,0.93 [0.66-1.31],0.6743228280384972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,21522,195,1.24 [0.98-1.59],0.0788200051037492
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23146,176,1.26 [0.98-1.63],0.0741326311994245
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Motor neuron disease,15504,145,1.01 [0.75-1.36],0.9532615569418686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23062,60,0.89 [0.56-1.44],0.6449963124386744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22710,932,1.15 [1.03-1.30],0.0150929054453386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,21891,3560,1.06 [1.00-1.13],0.0628049880319173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22852,237,0.96 [0.75-1.22],0.7209900857845184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22159,381,1.18 [0.99-1.42],0.0641043995017221
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23078,342,1.02 [0.84-1.24],0.8306718591575023
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18180,606,1.06 [0.92-1.23],0.4260811621826801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22625,75,0.81 [0.52-1.26],0.359474599330386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22701,151,0.90 [0.66-1.22],0.4827373506262082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22598,139,1.04 [0.76-1.41],0.8197960110994285
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21866,88,0.86 [0.57-1.28],0.4541617275303264
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other headache syndromes,21362,35,0.61 [0.31-1.20],0.1541198763599239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,23059,509,1.03 [0.87-1.20],0.7579969156648427
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,22007,680,1.08 [0.94-1.24],0.263414347282263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Parkinson's disease,23148,528,0.97 [0.83-1.14],0.6977984215584423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22576,26,1.14 [0.58-2.26],0.6999878889787634
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Restless leg syndrome,23170,51,1.10 [0.67-1.82],0.705755346425514
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,22872,613,1.09 [0.95-1.26],0.2279177135298483
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22789,53,0.98 [0.59-1.61],0.924325800472268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23155,169,1.06 [0.81-1.40],0.6562427828140771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21810,32,1.18 [0.63-2.20],0.5995191228210842
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23170,294,1.11 [0.90-1.37],0.3342683627347708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22640,146,0.86 [0.63-1.18],0.3589799234944238
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22636,85,1.13 [0.77-1.66],0.5184533857189896
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22837,294,0.90 [0.72-1.11],0.325409975351617
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22973,285,0.87 [0.70-1.08],0.2134084130717259
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22322,42,0.71 [0.39-1.29],0.2605987939561315
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22340,60,1.42 [0.93-2.16],0.1067995994390804
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23079,41,0.55 [0.30-1.04],0.0670430591475782
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22943,123,1.14 [0.83-1.57],0.4324272795242618
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2383,81,1.50 [1.03-2.17],0.0328881333253438
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2910,127,1.25 [0.92-1.72],0.1566989293820662
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22642,91,1.45 [1.04-2.04],0.0306922772148527
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22927,970,0.99 [0.88-1.11],0.8622078244399214
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22873,593,1.05 [0.90-1.21],0.5610198526923333
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22424,144,1.15 [0.85-1.54],0.3630965044960296
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23098,555,1.00 [0.86-1.17],0.9820977424589084
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23167,64,1.52 [1.02-2.25],0.0399745474474435
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23031,488,0.99 [0.84-1.17],0.9079548024101436
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23131,311,1.22 [1.00-1.48],0.0489158111432729
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23083,148,1.33 [1.01-1.75],0.0442144030745328
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22354,74,1.29 [0.87-1.92],0.2115572448047237
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22361,81,0.91 [0.60-1.38],0.6684555665889
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22324,44,1.08 [0.63-1.87],0.7800756312265501
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23080,659,1.12 [0.97-1.28],0.1172916298998461
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22598,177,0.86 [0.65-1.14],0.3039748225628993
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22572,29,0.63 [0.30-1.32],0.2205739665771208
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22912,92,1.19 [0.83-1.71],0.3527397911131466
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23045,225,1.21 [0.96-1.53],0.1073926423037554
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22707,164,1.21 [0.92-1.58],0.1675906043882845
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23019,84,1.22 [0.84-1.78],0.2942113842246102
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22868,447,1.23 [1.04-1.45],0.0130383950410236
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22675,124,1.37 [1.02-1.85],0.0381449656203431
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21824,1729,1.09 [1.00-1.19],0.0491830723981326
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23014,194,1.16 [0.90-1.49],0.2498187781834921
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23156,144,1.22 [0.91-1.62],0.1830624665895827
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22680,400,1.02 [0.85-1.22],0.873352252113083
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22882,62,1.18 [0.76-1.84],0.4596516157118273
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23158,55,1.62 [1.07-2.45],0.021848164258546
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22350,70,0.75 [0.47-1.19],0.2223764444549348
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22416,136,1.03 [0.76-1.41],0.8324069354914709
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22083,126,1.21 [0.89-1.65],0.2222816368963941
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22592,49,0.85 [0.50-1.46],0.5572406497741356
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22019,62,0.95 [0.60-1.52],0.8397454286234193
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22472,51,0.90 [0.53-1.53],0.7035418912540901
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22620,199,1.25 [0.98-1.60],0.0666398535290329
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22392,112,0.94 [0.66-1.34],0.7371753184400094
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22073,116,1.31 [0.96-1.78],0.0906821196828395
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22045,88,1.08 [0.74-1.59],0.688080774234978
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21531,1436,1.05 [0.96-1.16],0.3037436467234224
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22337,57,0.93 [0.57-1.53],0.7795121381265971
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22930,379,1.32 [1.11-1.57],0.0018434652595817
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22619,68,1.48 [1.00-2.19],0.0492476370781035
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22716,165,1.19 [0.91-1.56],0.2142288317418555
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22997,57,0.78 [0.47-1.30],0.3467131187450932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23127,118,1.06 [0.76-1.47],0.7502596646694049
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23040,105,1.17 [0.83-1.65],0.3667226970156709
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22988,48,0.87 [0.51-1.49],0.6208355740851881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22991,51,1.39 [0.88-2.20],0.1584942948770723
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23075,929,1.10 [0.98-1.24],0.1036331589406317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22836,690,1.16 [1.02-1.33],0.0286485989692008
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22267,121,0.67 [0.47-0.96],0.0287831777902531
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22228,82,1.42 [0.99-2.04],0.0584593269222181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute pharyngitis,22962,60,0.87 [0.54-1.41],0.5775250137092431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23087,185,0.97 [0.74-1.27],0.8449668757989903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22962,60,1.09 [0.69-1.73],0.7171689017035984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza,20950,103,1.12 [0.79-1.59],0.5234414444467229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20947,100,1.18 [0.83-1.67],0.3639824352109747
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15203,101,1.04 [0.73-1.49],0.8090678490352856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic rhinitis,23064,257,0.96 [0.76-1.20],0.6955835900116223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16152,1386,1.07 [0.97-1.18],0.1581762534901059
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16463,1361,1.08 [0.98-1.18],0.1414571346265042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22800,147,1.24 [0.94-1.64],0.1352335503112767
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20941,94,1.34 [0.96-1.89],0.0889914400364952
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,20160,281,1.13 [0.92-1.40],0.2382202156562864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19921,42,1.96 [1.28-3.01],0.0020049134534877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22353,2474,1.09 [1.01-1.17],0.0220519986742625
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21765,75,0.99 [0.65-1.50],0.9581666372168894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,21846,156,1.41 [1.08-1.83],0.0102137070613451
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22953,1264,1.08 [0.97-1.19],0.1424388259613923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,21828,138,1.18 [0.88-1.58],0.2664823858381554
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21223,5124,1.06 [1.00-1.11],0.0329350802267404
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22073,383,1.01 [0.84-1.21],0.9486468773017568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,21985,296,1.09 [0.89-1.34],0.4030481037192046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,20218,339,1.12 [0.93-1.36],0.2379810469884084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22269,323,1.29 [1.06-1.55],0.0093693523370488
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22928,2081,1.11 [1.02-1.20],0.011542911621671
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,22296,350,1.37 [1.15-1.64],0.0005120510591695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Later onset COPD,22142,968,1.07 [0.95-1.20],0.2831804961234959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23153,415,1.07 [0.89-1.28],0.4682317884357475
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,21827,137,1.26 [0.94-1.69],0.1166463177883466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22904,959,1.20 [1.07-1.35],0.0016921982405997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,22898,2121,1.11 [1.03-1.20],0.0062945470322559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22533,843,1.04 [0.92-1.18],0.5364238681514866
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other pleural conditions,20843,66,1.61 [1.12-2.32],0.0096126384074947
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23078,431,1.37 [1.17-1.61],0.0001079171960849
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23051,1351,1.21 [1.10-1.33],6.340459082413605e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,21854,1077,1.06 [0.95-1.19],0.2749398452530283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural plaque,21032,255,1.08 [0.86-1.35],0.5181049993613134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22670,1823,1.11 [1.02-1.21],0.0153671061785875
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23056,318,1.06 [0.87-1.30],0.5579360091620502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumothorax,20916,139,0.81 [0.59-1.12],0.2080152515845465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pollen allergy,23155,225,1.03 [0.81-1.31],0.8046193903762735
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pulmonary oedema,22714,67,1.05 [0.67-1.64],0.8290815715276088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15157,55,1.43 [0.91-2.24],0.1245080472317585
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22889,944,1.19 [1.06-1.34],0.0025412546375019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21949,259,0.95 [0.76-1.19],0.6607040414433398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Viral pneumonia,21119,272,1.09 [0.87-1.35],0.4622480168123775
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22817,231,0.98 [0.77-1.25],0.8507167126209856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10091,110,0.71 [0.49-1.04],0.0757046620638833
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16190,89,1.30 [0.90-1.87],0.1655869403143793
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,23044,140,1.08 [0.80-1.45],0.6346867187517513
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute gastritis,17502,89,1.19 [0.82-1.72],0.366471854479538
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,21871,186,0.95 [0.72-1.25],0.7130964923363983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute peritonitis,22823,94,1.02 [0.70-1.49],0.9143431115077444
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22314,111,0.89 [0.62-1.27],0.5058487886604695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Barrett oesophagus,17923,510,0.95 [0.80-1.11],0.5053705935125015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21803,118,0.85 [0.60-1.20],0.3550295518897756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22778,118,0.84 [0.59-1.19],0.3316142485091511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,21892,207,1.18 [0.92-1.51],0.1816773210598163
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,22437,752,1.12 [0.98-1.27],0.0962795762282119
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,17670,257,0.94 [0.75-1.18],0.6083655397966783
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21741,56,0.87 [0.52-1.45],0.5974645557028415
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22974,125,0.69 [0.49-0.99],0.0423267401833777
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,21584,91,1.31 [0.92-1.86],0.1333930893296243
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Collagenous colitis,21783,48,1.15 [0.69-1.91],0.5927671981935847
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23009,213,0.99 [0.77-1.27],0.9412168839623604
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,23015,1546,1.05 [0.96-1.15],0.2917928617074134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,21823,88,1.02 [0.69-1.50],0.9323150510902384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22837,62,0.89 [0.55-1.43],0.624802842892502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21810,75,1.32 [0.89-1.95],0.1650255431211827
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,22548,217,1.27 [1.01-1.60],0.0438395811771417
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19649,1889,1.01 [0.93-1.10],0.7707987960336
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,23072,168,1.04 [0.79-1.37],0.7850317909043002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,23036,833,0.99 [0.87-1.12],0.8781070054427865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21225,3812,1.03 [0.97-1.09],0.2986875447741267
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22821,490,1.13 [0.96-1.33],0.1287169142868905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23123,394,1.07 [0.90-1.28],0.4514739705338312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22436,105,1.20 [0.86-1.69],0.2876958430220736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22299,65,0.84 [0.52-1.33],0.4509442047692413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22867,1374,1.08 [0.98-1.19],0.1043099272078361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of tongue,22320,105,0.87 [0.61-1.26],0.4711619999612233
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22812,1127,1.04 [0.93-1.16],0.5164634879335929
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19059,2958,0.99 [0.92-1.05],0.6627143854218902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,17675,262,1.01 [0.81-1.26],0.9419288048273328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23060,205,0.98 [0.76-1.27],0.8974598893958574
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23097,46,1.15 [0.69-1.92],0.5999100256248318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22349,146,0.73 [0.53-1.02],0.0618626891614395
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16277,176,0.97 [0.74-1.28],0.849266460689258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,17828,415,0.88 [0.73-1.05],0.1585555799441139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,17767,354,1.09 [0.90-1.32],0.3680222016447161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19493,2080,1.05 [0.97-1.13],0.2683847023929624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17994,581,1.04 [0.90-1.21],0.5971618398087029
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17728,7750,1.02 [0.98-1.07],0.2529192160087944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,22631,1138,1.06 [0.95-1.18],0.3048792281924408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22373,42,1.18 [0.69-2.01],0.5553582933586265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17038,1200,0.94 [0.84-1.04],0.2239664990443055
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22283,80,1.04 [0.70-1.57],0.8329847363906073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,21185,3425,1.02 [0.96-1.09],0.4611609893585888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,23100,43,1.32 [0.80-2.19],0.2813262850087906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impaction of intestines,16148,47,1.14 [0.68-1.94],0.6140497130901696
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,19342,1582,1.04 [0.95-1.14],0.4279926380774627
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17952,192,0.98 [0.75-1.27],0.878740222565733
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16189,88,0.89 [0.59-1.32],0.5571684345731679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21597,104,1.29 [0.93-1.80],0.1290305721326404
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16367,266,0.82 [0.65-1.04],0.1003101613984801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23128,365,0.95 [0.79-1.16],0.6381553859544455
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22392,657,1.12 [0.98-1.29],0.097581911116516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22591,856,1.09 [0.97-1.23],0.1655600762265753
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17620,207,1.04 [0.81-1.33],0.773838025524068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,18016,603,1.09 [0.94-1.26],0.2366680624886723
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23119,111,1.36 [1.00-1.86],0.0504573184213505
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17833,73,0.96 [0.63-1.48],0.863814018968943
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17491,1390,1.01 [0.91-1.11],0.9125691864688376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21937,252,0.95 [0.75-1.20],0.6615498768100887
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21797,112,1.28 [0.93-1.77],0.132539465870375
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,17925,1824,0.98 [0.90-1.07],0.6521160631727976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,21411,5310,0.99 [0.94-1.04],0.7067589047818396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22282,174,1.23 [0.95-1.59],0.1183741621654337
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,22866,663,0.96 [0.83-1.11],0.6085197963552875
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,713,1.01 [0.88-1.16],0.8951332611555173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21819,134,0.88 [0.63-1.22],0.433365075698767
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23054,325,1.11 [0.91-1.34],0.318540544466191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18189,776,1.00 [0.88-1.14],0.9441304794781864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22643,1150,1.05 [0.95-1.17],0.3253267223245865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22496,165,1.23 [0.94-1.60],0.1361035986411158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17682,1581,1.03 [0.94-1.13],0.4832768246386458
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19232,1819,1.02 [0.94-1.11],0.6319795074405625
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22295,92,0.72 [0.48-1.08],0.1154608786644858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22487,752,1.11 [0.97-1.26],0.1261519092655632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16441,340,0.99 [0.81-1.21],0.9125106273696424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23089,55,1.28 [0.81-2.01],0.2941234503768356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16566,465,0.99 [0.83-1.17],0.9054029799023232
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21653,160,1.17 [0.89-1.54],0.2622545926196932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23157,42,1.01 [0.58-1.77],0.9707691535838444
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22339,99,1.22 [0.87-1.73],0.2539111209125065
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Toxic colitis,21777,42,0.87 [0.48-1.57],0.6489550069862833
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17696,283,1.01 [0.81-1.25],0.9405888048561848
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,21878,143,1.07 [0.79-1.44],0.6676213900453807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21855,120,0.96 [0.69-1.34],0.8203335081216094
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,18115,355,1.01 [0.84-1.23],0.8802924040433421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16254,153,0.82 [0.60-1.11],0.204102214649076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,18011,251,0.97 [0.77-1.22],0.789919299176943
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Volvulus,16175,74,0.86 [0.55-1.34],0.5044603816124109
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23097,318,0.96 [0.78-1.18],0.7083854357399166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22860,65,1.48 [0.99-2.20],0.0541282401262659
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21223,92,1.07 [0.74-1.56],0.7061399348055253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22443,727,1.01 [0.88-1.15],0.924556974103384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21913,197,1.07 [0.83-1.38],0.5864157643274066
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21592,461,1.11 [0.94-1.31],0.2377719843002717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22882,261,1.36 [1.11-1.68],0.0030489321129652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23082,461,1.28 [1.09-1.50],0.0020565836346621
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22664,43,1.19 [0.70-2.02],0.514328324282622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21719,3097,1.02 [0.96-1.09],0.5308014184915995
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22734,398,1.01 [0.84-1.21],0.9051607523748192
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22624,288,1.03 [0.83-1.28],0.779004714491587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22713,997,1.01 [0.90-1.13],0.9006372545333496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23161,30,1.04 [0.54-2.01],0.904481034412938
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21154,23,1.84 [1.00-3.39],0.0491598852774737
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22392,56,1.09 [0.68-1.76],0.7104053469497237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22878,257,1.37 [1.11-1.68],0.0031538280697528
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21602,471,1.02 [0.87-1.21],0.7784119866196201
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21208,77,1.11 [0.74-1.66],0.6178405028585281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23103,83,1.36 [0.95-1.96],0.0936503361708076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21930,214,1.15 [0.91-1.47],0.2416652694678787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23006,211,1.08 [0.85-1.38],0.5281778816227407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22691,70,1.53 [1.05-2.23],0.0261567034289551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21196,65,1.11 [0.72-1.72],0.6434042882684038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22727,1596,1.08 [0.98-1.18],0.1050972469030778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21639,508,1.05 [0.90-1.23],0.520686917450319
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21211,80,1.08 [0.72-1.62],0.7014751465909314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23085,290,1.13 [0.92-1.39],0.2608808772293973
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22672,51,1.26 [0.78-2.04],0.3488095196466892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23049,254,1.14 [0.91-1.42],0.2600021728616382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23116,337,0.93 [0.76-1.13],0.4632155621035859
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21216,85,1.11 [0.76-1.63],0.5849983596134981
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21397,266,0.79 [0.62-1.00],0.0453125919033116
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23109,330,0.95 [0.77-1.16],0.594136707714189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21393,262,1.23 [0.99-1.52],0.0626035646706769
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23144,124,1.38 [1.03-1.86],0.0326764260029073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19983,84,0.95 [0.64-1.42],0.8150585874776208
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21137,4637,1.03 [0.98-1.08],0.2905156030385633
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19770,3270,1.01 [0.95-1.07],0.7943308273678664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19968,69,0.93 [0.60-1.46],0.7678254693641826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20343,145,1.17 [0.87-1.56],0.3003440004150344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20340,142,0.98 [0.72-1.34],0.908778407750819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22970,67,1.23 [0.81-1.87],0.3223162055461137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20277,79,1.10 [0.73-1.64],0.6553581056292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17347,847,1.07 [0.95-1.21],0.2654570129486491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23056,147,1.07 [0.79-1.44],0.668703378848923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20462,264,1.34 [1.09-1.64],0.0056058955618035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19712,6085,1.05 [1.00-1.10],0.0416313607430135
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22136,88,0.81 [0.54-1.22],0.3187589826786605
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20062,163,0.85 [0.63-1.15],0.2955167774604382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20324,425,1.08 [0.90-1.28],0.4054871544421774
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22377,2179,1.06 [0.99-1.15],0.114424721798914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20257,358,0.90 [0.74-1.10],0.317749746311236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19951,52,1.06 [0.65-1.75],0.8048296128689401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19993,94,1.09 [0.75-1.57],0.6514232715538117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22858,28,1.46 [0.79-2.71],0.2246927162337612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17919,1419,1.00 [0.91-1.10],0.9744771772417548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17446,946,1.05 [0.93-1.18],0.4160347658444401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23038,933,1.06 [0.94-1.19],0.3204654315971117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16546,46,0.87 [0.51-1.50],0.6212519158053968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16579,79,1.25 [0.85-1.83],0.2619310369920482
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20159,260,1.16 [0.93-1.44],0.1958204393649203
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17108,608,1.12 [0.98-1.30],0.1052309001472069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20238,40,1.55 [0.95-2.52],0.0769251547745898
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20722,524,1.09 [0.93-1.27],0.2970580867793182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20460,262,1.18 [0.95-1.47],0.1271432286885242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17071,571,1.07 [0.92-1.24],0.3828651709296076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19963,64,1.10 [0.70-1.73],0.6696652091166487
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19952,53,1.21 [0.75-1.95],0.4260868034834768
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22137,89,1.03 [0.70-1.52],0.8634156897703028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22887,839,0.99 [0.87-1.13],0.9062093935672682
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22433,385,0.94 [0.78-1.14],0.5245807964117966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23088,274,1.19 [0.96-1.47],0.1143388888442182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18331,1831,1.03 [0.95-1.12],0.4936853609811662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16551,51,1.21 [0.75-1.96],0.4360890392899327
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19980,81,1.20 [0.81-1.77],0.3569536888086654
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16552,52,0.90 [0.54-1.50],0.6771715875023872
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16546,46,0.90 [0.53-1.55],0.709523175184713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22232,184,1.06 [0.81-1.38],0.6759291147669118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22206,158,1.09 [0.82-1.45],0.5370530957894809
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23135,85,1.13 [0.77-1.66],0.516883756982065
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21691,1493,1.07 [0.97-1.17],0.1633729213696672
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19960,61,1.17 [0.75-1.83],0.4857612038461366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16540,40,1.01 [0.57-1.80],0.966552412360412
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20797,599,1.18 [1.02-1.36],0.0260129209273313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18162,1662,1.08 [0.99-1.18],0.0850931530493138
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22881,51,1.40 [0.88-2.22],0.1505008919175212
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23152,59,1.64 [1.10-2.44],0.0145293337976771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19977,78,1.07 [0.71-1.62],0.7507341011268914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20867,968,1.17 [1.05-1.31],0.0051110246901882
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19991,92,0.94 [0.63-1.39],0.7516045315581064
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17672,1172,1.05 [0.95-1.16],0.366197856213699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22133,85,1.03 [0.69-1.52],0.8946437133587818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19940,41,1.44 [0.86-2.40],0.1653064097473272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20309,111,0.93 [0.65-1.33],0.6933584525909877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20396,497,1.05 [0.89-1.23],0.5838341449897783
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23021,191,0.98 [0.75-1.28],0.9033420889389484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20672,474,1.07 [0.91-1.26],0.4098384800884198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23097,269,1.16 [0.94-1.44],0.1702819394416886
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23155,38,1.64 [1.00-2.69],0.049936539841461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20044,145,0.93 [0.68-1.27],0.6444700240371937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19001,562,1.15 [0.99-1.34],0.062019484498187
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20371,472,1.22 [1.04-1.43],0.0150919774091853
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20225,326,0.89 [0.72-1.09],0.2539968881070406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16530,30,0.88 [0.45-1.72],0.7036448078229884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18697,2197,1.05 [0.98-1.14],0.1778864988012747
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16937,437,1.01 [0.85-1.19],0.9482859928761777
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22993,163,0.91 [0.68-1.23],0.5503116264601604
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23096,46,0.97 [0.56-1.66],0.9038292218765132
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21240,46,1.08 [0.63-1.83],0.7861161032669736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16561,61,1.52 [1.03-2.25],0.034838597850965
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20286,88,1.49 [1.06-2.10],0.0211431955128389
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16782,282,1.19 [0.97-1.46],0.0947440403844275
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20168,269,1.09 [0.87-1.36],0.44471287965555
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20408,210,1.27 [1.00-1.60],0.0478917167463907
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20291,93,1.47 [1.05-2.05],0.0234716460975623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18402,30,1.31 [0.73-2.37],0.3632940291500115
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23156,39,1.60 [0.98-2.63],0.0614762449045756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20410,511,1.08 [0.92-1.27],0.3257385873064389
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22848,18,1.05 [0.45-2.44],0.9138747175725688
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22119,2220,1.05 [0.97-1.13],0.2224009522801781
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20000,101,1.02 [0.71-1.47],0.9171744013027986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20691,493,1.15 [0.98-1.35],0.0870869544720761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22143,190,1.01 [0.78-1.31],0.9420181083347344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20322,124,1.31 [0.97-1.78],0.0794409493858003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21478,1280,1.09 [0.99-1.21],0.0835734020334465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21000,802,1.10 [0.97-1.25],0.1457725043320032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19940,41,1.12 [0.64-1.94],0.6908150112483681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22868,38,1.91 [1.20-3.02],0.0060586520535424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20016,117,1.13 [0.81-1.58],0.4580905922757796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19920,21,1.00 [0.44-2.26],0.993397320510204
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16560,60,0.83 [0.51-1.34],0.4432451465036674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22198,1818,1.12 [1.03-1.22],0.0103432909905894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22711,387,0.96 [0.80-1.16],0.6992041898349115
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22458,134,0.90 [0.65-1.24],0.5107447581378761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21875,1495,1.04 [0.95-1.14],0.4183931175393697
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22922,82,1.49 [1.04-2.13],0.0292977671921389
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22896,345,1.04 [0.86-1.27],0.669127944468424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,20375,205,1.08 [0.84-1.39],0.5419083916069425
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,20482,102,1.45 [1.04-2.01],0.0284718209834823
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.06 [1.00-1.13],0.0523599246723376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20858,5434,1.04 [0.99-1.09],0.1326615576466764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22941,101,1.55 [1.13-2.12],0.005959530593786
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,1.02 [0.79-1.32],0.8689472702342528
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20479,357,1.17 [0.97-1.42],0.0909625564026622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.06 [0.99-1.14],0.1147914214231179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,1.09 [0.86-1.38],0.4730608265985957
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20243,73,0.80 [0.51-1.26],0.3349115241800989
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,0.85 [0.59-1.22],0.3867337317345171
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23159,58,0.89 [0.54-1.45],0.6328031036082062
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23164,54,0.66 [0.38-1.12],0.122588698591512
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22368,2198,1.06 [0.99-1.15],0.1101286409787963
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21094,924,1.11 [0.98-1.25],0.0900934766639925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23097,546,1.06 [0.90-1.23],0.4888396344407679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.07 [0.87-1.31],0.5156383422147081
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,1.17 [0.95-1.44],0.1489120975772326
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.90 [0.70-1.16],0.4052770640534547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23153,46,1.19 [0.71-1.98],0.5081154845180696
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21670,1500,1.11 [1.01-1.21],0.0326883294585911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20520,398,1.17 [0.98-1.40],0.0818705688970106
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22737,186,1.02 [0.78-1.33],0.8755058551666532
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22898,58,1.03 [0.64-1.66],0.9067825368052848
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,1.18 [0.95-1.47],0.1307929195489349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22869,2747,1.08 [1.01-1.16],0.0223733109774466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20192,70,1.27 [0.84-1.91],0.2550492586600041
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20531,151,0.91 [0.67-1.24],0.5653116506769221
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22397,73,1.18 [0.79-1.77],0.4127401355634024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20458,288,0.97 [0.78-1.21],0.7989469954114896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22823,499,0.96 [0.81-1.13],0.5977728825821413
